Financhill
Back

Veracyte 10K Form

Buy
68

VCYT
Veracyte

Last Price:
35.91
Seasonality Move:
7.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VCYT News And Ratings

See the #1 stock for the next 7 days that we like better than VCYT

VCYT Financial Statistics

Sales & Book Value

Annual Sales: $361.05M
Cash Flow: $26.81M
Price / Cash Flow: 66.67
Annual Sales: $14.76
Price / Book: 2.44

Profitability

EPS (TTM): -0.75000
Net Income (TTM): $-54.04M
Gross Margin: $248.15M
Return on Equity: -4.97%
Return on Assets: -4.63%

Veracyte Earnings Forecast

Key Veracyte Financial Ratios

  • The Gross Profit Margin over the past 13 years for VCYT is 68.73%.
  • The Selling, General & Administrative Expenses for VCYT have been equal to 51.03% of Gross Profit Margin.
  • The Research & Development expenses have been 15.87% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • The Net Earning history of VCYT is -20.61% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Veracyte Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VCYT
CUSIP: 92337F
Website: veracyte.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.44
Quick Ratio: 3.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 41.7

VCYT Technical Analysis vs Fundamental Analysis

Buy
68
Veracyte (VCYT) is a Buy

Is Veracyte a Buy or a Sell?

  • Veracyte stock is rated a Buy
    The current Veracyte [VCYT] share price is $35.93. The Score for VCYT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.